Joint SFI / Johnson and Johnson Services Inc (JJSI) - Healthcare Innovation Award Programme
SFI with the support of the Johnson & Johnson Corporate Office of Science and Technology (COSAT) in cooperation with Advanced Technologies and Regenerative Medicine LLC, (ATRM), are undertaking a joint initiative to strengthen particular areas of healthcare research. Under this 2010 joint initiative, the focus will be on funding preliminary proof of concept proposals in the area of Immune-modulated Inflammation Research. It is envisaged that participation in this initiative will allow SFI researchers and COSAT-ATRM to identify technology needs and influence future industry standards. This Programme will help accelerate the translation of basic research into therapies useful in the treatment of inflammatory diseases.
The jointly managed Healthcare Innovation Programme is intended to encourage biomedical exploration in the areas of Immune-modulated inflammatory diseases including but not limited to Osteoarthritis, Rheumatoid Arthritis, Graft-vs-host Disease, Psoriasis, Lung disease, Renal Disease, Inflammatory Bowel Disease, and Neurodegenerative Diseases etc.
The budget available, on a competitive basis, is up to €50,000 direct costs for a period of 12 calendar months.
Downloads
Healthcare Innovation Award Programme Call (word) (pdf)
Deadlines
Deadline for submission of proposals is 13.00hrs on 30th July 2010
SFI reserves the right to make amendments to the documents if required. Please ensure that you are referring to the most recent version of the Call document and FAQs. Research Offices will be contacted in the event of any updates to the call document.
How to apply
As detailed in the Healthcare Innovation Award Programme Call document, applications should be submitted electronically, in the form of a single Adobe PDF document, from the proposed host institute research office to HIPA@sfi.ie,
Further Information
Webinar PowerPoint presentation
The webinar FAQs are available here
